Lithium Other names: Lithium salts

Chemical formula: Li  Molecular mass: 6.941 g/mol  PubChem compound: 28486

Active ingredient description

Little is known about the way the lithium ion can modify neurotransmission within the CNS. Many of the proposed mechanisms have suggested an inhibitory effect on components of various neurotransmitter signalling pathways, such as cyclic AMP formation, cyclic GMP formation, G-proteins or inositol phosphate metabolism.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
D11AX04 Lithium succinate D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX04
N05AN01 Lithium N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AN Lithium
Discover more medicines within N05AN01
V04CX11 V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CX Other diagnostic agents
Discover more medicines within V04CX11

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
LI-LIQUID Solution for oral administration Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 7439-93-2
DrugBank Drug: DB01356
PubChem Compound: 28486
RxNorm Ingredient: 6448
SNOMED-CT Concept: 85899009
Lithium (substance)
UNII Identifier: 8H8Z5UER66
LITHIUM CATION

Medicines

Lithium is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Ecuador (EC)

Estonia (EE)

Finland (FI)

  • LITO as Lithium carbonate

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

  • LIMAS as LITHIUM CARBONATE

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.